These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4810236)

  • 21. In vitro augmentation of cytotoxicity against tumor cell lines by mumps virus.
    Morales A; Ottenhof P; Elliott M
    Invest Urol; 1980 Jan; 17(4):284-7. PubMed ID: 6927978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia, and trophoblast neoplasms.
    Pattillo RA
    Prog Clin Biol Res; 1981; 70():259-68. PubMed ID: 6273935
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cell-mediated immunity in the toxemia of pregnancy using the leukocyte migration inhibition test].
    Peng HQ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Mar; 20(2):96-8, 127. PubMed ID: 4006593
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
    Takada M
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for specific tumor cytotoxic antibodies in serum of cervical cancer patients.
    Weintraub I; Klisak I; Lagasse LD; Byfield JE
    Am J Obstet Gynecol; 1973 Aug; 116(7):985-92. PubMed ID: 4124024
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of ovarian carcinoma tissue culture in the leukocyte migration inhibition test].
    Tosner J; Fixa B; Jirkalová V; Donát J
    Cas Lek Cesk; 1987 Apr; 126(14):439-41. PubMed ID: 3581139
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
    Chen SS; Koffler D; Cohen CJ
    Am J Obstet Gynecol; 1975 Jan; 121(1):91-5. PubMed ID: 1115121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoimmune processes in uterine myoma].
    Zudikova SI
    Akush Ginekol (Mosk); 1980 Jan; (1):29-30. PubMed ID: 7377471
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytotoxic lymphocytes. I. Destruction of neoplastic cells by lymphocytes in cultures of human origin.
    Sinkovics JG; Dreyer DA; Shirato E; Cabiness JR; Shullenberger CC
    Tex Rep Biol Med; 1971; 29(2):227-42. PubMed ID: 5098985
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic reactivity of female patients with genital cancer: status in preinvasive, locally invasive, and disseminated disease.
    Khoo SK; Mackay EV
    Am J Obstet Gynecol; 1974 Aug; 119(8):1018-25. PubMed ID: 4603198
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective cytotoxicity of peritoneal leucocytes. A preliminary report.
    Holtermann OA; Lisafeld BA; Klein E
    J Med; 1972; 3(6):359-62. PubMed ID: 4358879
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.
    Hess AD; Gall SA; Dawson JR
    Cancer Res; 1979 Jul; 39(7 Pt 1):2381-9. PubMed ID: 36225
    [No Abstract]   [Full Text] [Related]  

  • 34. Mixed wife-husband leukocyte cultures in disturbed and pathological pregnancies. Further studies.
    Halbrecht IG; Komlos L
    Isr J Med Sci; 1974 Sep; 10(9):1100-5. PubMed ID: 4279893
    [No Abstract]   [Full Text] [Related]  

  • 35. [Macrophage transformation of blood mononuclear cells in patients with cancer of the uterine body].
    Movsesian MA; Adamian RT; Khachatrian ShV
    Vopr Onkol; 1990; 36(3):318-20. PubMed ID: 2330682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of a new membrane associated placental protein 4 (PP4) in gynecologic malignancies.
    Inaba N; Shirotake S; Ota Y; Fukazawa I; Nito A; Ijichi M; Takamizawa H; Bohn H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):265-6. PubMed ID: 2937860
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA
    Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated immune reaction to two gynecologic malignant tumors.
    DiSala PJ; Rutledge FN; Smith JP; Sinkovics JG
    Cancer; 1971 Nov; 28(5):1129-37. PubMed ID: 5125661
    [No Abstract]   [Full Text] [Related]  

  • 39. [Symtomatology of immunobiological reactions in the early stage of cancer].
    Müller J; Sturík J; Kepertová A
    Wien Z Inn Med; 1966 Feb; 47(2):61-5. PubMed ID: 6005155
    [No Abstract]   [Full Text] [Related]  

  • 40. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.